Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

C. Massard | Researchclopedia

Back to researchers

C. Massard

Institut Gustave Roussy

115

Works

428

Citations

12

h-index

16

i10-index

Research Topics

Cancer Genomics and Diagnostics Prostate Cancer Treatment and Research Cancer Immunotherapy and Biomarkers

Affiliations

Université Paris-Sud2015–2016

Garvan Institute of Medical Research2012–2012

Inserm2021–2023

Université Paris-Saclay2009–2023

Institut Gustave Roussy2009–2025

Top Works

Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers

Jean‐Charles Soria,C. Massard,et al.

200981 citations

Lung Cancer Treatments and Mutations

Renal cell carcinoma treatment

Why do residents choose the medical oncology specialty? Implications for future recruitment—results of the 2007 French Association of Residents in Oncology (AERIO) Survey

Yohann Loriot,Laurence Albiges‐Sauvin,et al.

200932 citations

A phase I study of AVE1642, a humanized monoclonal antibody IGF-1R (insulin like growth factor1 receptor) antagonist, in patients(pts) with advanced solid tumor(ST)

A. W. Tolcher,A. Patnaik,et al.

200832 citations

A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors

C. Massard,Jean‐Charles Soria,et al.

201630 citations

Dasatinib in patients with hormone-refractory progressive prostate cancer: A phase II study

E. Y. Yu,George Wilding,et al.

200827 citations

Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone

C. Massard,Joaquı́n Mateo,et al.

201627 citations

A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma

Antoine Hollebecque,Éric Deutsch,et al.

201326 citations

302 A phase 1 study of EPZ-6438 (E7438), an Enhancer of Zeste-Homolog 2 (EZH2) inhibitor: Preliminary activity in INI1-negative tumors

Antoîne Italiano,Heike Keilhack,et al.

201517 citations

ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy

Benjamin Besse,C. Massard,et al.

201015 citations